crownbio
Crown Bioscience (CrownBio) is a global contract research organization (CRO) specializing in translational oncology and immuno-oncology drug discovery. It provides preclinical and translational services to biotech and pharmaceutical companies, including in vitro drug screening (cell lines, organoids, panels), in vivo studies (PDX, CDX, syngeneic and humanized models), DMPK/toxicology, preclinical imaging, and biomarker analysis spanning genomics (NGS, single-cell sequencing), proteomics, spatial biology, and flow cytometry. CrownBio also operates public web-browsable cancer-model databases — a PDX Model Database (2,500+ models), an Organoid Models Database (600+ models), an IO Murine Models Database, and a Cell Line / CDX Database — searchable through a Multi-Model Search interface. There is no public developer API or programmatic data access; the databases are web interfaces. This profile was surfaced as a portfolio company of Qiming Venture Partners and enriched by the API Evangelist pipeline.
crownbio is profiled on the APIs.io network. Tagged areas include Company, Contract Research Organization, Oncology, Drug Discovery, and Preclinical.
crownbio’s developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API